GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Longduoduo Co Ltd (OTCPK:LDDD) » Definitions » EBITDA Margin %

Longduoduo Co (Longduoduo Co) EBITDA Margin % : 42.23% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Longduoduo Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Longduoduo Co's EBITDA for the three months ended in Mar. 2024 was $0.76 Mil. Longduoduo Co's Revenue for the three months ended in Mar. 2024 was $1.79 Mil. Therefore, Longduoduo Co's EBITDA margin for the quarter that ended in Mar. 2024 was 42.23%.


Longduoduo Co EBITDA Margin % Historical Data

The historical data trend for Longduoduo Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longduoduo Co EBITDA Margin % Chart

Longduoduo Co Annual Data
Trend Jun21 Jun22 Jun23
EBITDA Margin %
-90.82 -231.32 2.54

Longduoduo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -162.50 32.98 28.36 17.90 42.23

Competitive Comparison of Longduoduo Co's EBITDA Margin %

For the Diagnostics & Research subindustry, Longduoduo Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longduoduo Co's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Longduoduo Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Longduoduo Co's EBITDA Margin % falls into.



Longduoduo Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Longduoduo Co's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=0.097/3.819
=2.54 %

Longduoduo Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=0.756/1.79
=42.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longduoduo Co  (OTCPK:LDDD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Longduoduo Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Longduoduo Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Longduoduo Co (Longduoduo Co) Business Description

Traded in Other Exchanges
N/A
Address
Ordos Street, 419, Floor 4, Comprehensive Building, Second Light Hospital, Yuquan District, Inner Mongolia, Hohhot, CHN, 010000
Longduoduo Co Ltd through its operating subsidiaries engaged in the business of providing preventive healthcare solutions. It provides a wide range of comprehensive preventive healthcare services including disease screening, healthcare treatments, healthcare products, and other services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. The company's revenues are generated from its customers in the People's Republic of China.

Longduoduo Co (Longduoduo Co) Headlines

No Headlines